Ryuichiro Tamada

748 total citations
40 papers, 598 citations indexed

About

Ryuichiro Tamada is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ryuichiro Tamada has authored 40 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 10 papers in Oncology. Recurrent topics in Ryuichiro Tamada's work include Gastric Cancer Management and Outcomes (15 papers), Metastasis and carcinoma case studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ryuichiro Tamada is often cited by papers focused on Gastric Cancer Management and Outcomes (15 papers), Metastasis and carcinoma case studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ryuichiro Tamada collaborates with scholars based in Japan. Ryuichiro Tamada's co-authors include Keizō Sugimachi, Shunichi Tsujitani, Kiyoshi Inokuchi, Hideaki Anai, Yoshihiko Maehara, Takeshi Okamura, Daisuke Korenaga, T Furukawa, Kosei Yasumoto and K Sugimachi and has published in prestigious journals such as Cancer, British journal of surgery and Cancer Letters.

In The Last Decade

Ryuichiro Tamada

38 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuichiro Tamada Japan 13 267 193 186 115 106 40 598
Tatsuhei Kondo Japan 16 129 0.5× 148 0.8× 230 1.2× 162 1.4× 85 0.8× 74 719
Fukuto Maruta Japan 14 224 0.8× 435 2.3× 96 0.5× 171 1.5× 114 1.1× 31 661
T Hisatsugu Japan 12 151 0.6× 150 0.8× 213 1.1× 118 1.0× 46 0.4× 48 485
Jackie Baker United States 7 279 1.0× 166 0.9× 238 1.3× 117 1.0× 32 0.3× 12 583
Maolin Jin China 12 471 1.8× 564 2.9× 125 0.7× 100 0.9× 46 0.4× 23 819
Weon Seon Hong South Korea 9 81 0.3× 166 0.9× 84 0.5× 145 1.3× 91 0.9× 30 425
Junbo Hong China 16 221 0.8× 305 1.6× 145 0.8× 139 1.2× 68 0.6× 45 565
Hironobu Tsukamoto Japan 13 133 0.5× 166 0.9× 120 0.6× 124 1.1× 48 0.5× 32 485
Yoshinori Kikuchi Japan 13 122 0.5× 194 1.0× 155 0.8× 111 1.0× 31 0.3× 73 628
Matthew B. Sturm United States 12 133 0.5× 169 0.9× 143 0.8× 182 1.6× 147 1.4× 16 615

Countries citing papers authored by Ryuichiro Tamada

Since Specialization
Citations

This map shows the geographic impact of Ryuichiro Tamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichiro Tamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichiro Tamada more than expected).

Fields of papers citing papers by Ryuichiro Tamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichiro Tamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichiro Tamada. The network helps show where Ryuichiro Tamada may publish in the future.

Co-authorship network of co-authors of Ryuichiro Tamada

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichiro Tamada. A scholar is included among the top collaborators of Ryuichiro Tamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichiro Tamada. Ryuichiro Tamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Yuki, Saori Fukunaga, Masahiro Ohara, et al.. (2023). Assessment of the expression of microRNAs‑221‑3p, ‑146a‑5p, ‑16‑5p and BCL2 in oncocytic carcinoma of the breast: A case report. Oncology Letters. 26(6). 535–535. 2 indexed citations
2.
Iguchi, Tomohiro, Mizuki Ninomiya, Norifumi Harimoto, et al.. (2014). [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].. PubMed. 105(3). 79–83.
3.
Yasutomi, M, Toshio Takahashi, Susumu Kodaira, et al.. (1997). [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].. Gan to kagaku ryōhō. 24(13). 1953–60. 10 indexed citations
4.
Hirokawa, Mitsuyoshi, et al.. (1995). Stromal sarcoma of the breast, mimicking adenocarcinoma in fine needle aspiration cytology.. The Journal of the Japanese Society of Clinical Cytology. 34(6). 1228–1229. 1 indexed citations
5.
Maehara, Yoshihiko, et al.. (1989). Effect of glucocorticoid replacement on tumor growth after adrenalectomy in mice.. PubMed. 49(8). 2048–51. 4 indexed citations
7.
Niimoto, Minoru, Takao Hattori, Ryuichiro Tamada, et al.. (1987). Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report). Surgery Today. 17(5). 354–361. 12 indexed citations
8.
Tsujitani, Shunichi, T Furukawa, Ryuichiro Tamada, et al.. (1987). Langerhans cells and prognosis in patients with gastric carcinoma. Cancer. 59(3). 501–505. 108 indexed citations
9.
Anai, Hideaki, Yoshihiko Maehara, Hidetaka Masuda, et al.. (1986). In vitro chemosensitivity of various human tumors evaluated by succinate dehydrogenase inhibition (SDI) test (the second report). Gan to kagaku ryōhō. 13(8). 2544–2548. 2 indexed citations
10.
Korenaga, Daisuke, Masanobu Haraguchi, Shunichi Tsujitani, et al.. (1986). [Cytophotometric DNA analysis of gastric carcinoma--relationship between DNA ploidy and lymph node metastasis].. PubMed. 32(1). 45–9. 3 indexed citations
11.
Maehara, Yoshihiko, Hideaki Anai, Ryuichiro Tamada, & Keizō Sugimachi. (1986). Partial hepatectomy alters sensitivity of rat hepatocytes to 5-fluorouracil. Cancer Letters. 31(3). 227–233. 4 indexed citations
12.
Tamada, Ryuichiro, et al.. (1985). Synergistic effect of K-18 and concomitant hyperthermia for treatment of lewis lung carcinoma in mice. Surgery Today. 15(2). 173–176. 1 indexed citations
13.
Tamada, Ryuichiro, et al.. (1985). [Evaluation of splenectomy in total gastrectomy for gastric cancer].. PubMed. 86(9). 1124–7. 8 indexed citations
14.
Sasaki, Osamu, et al.. (1985). DNA cytophotometry on atypical glands in stomach carcinogenesis of dogs induced by N-methyl-N?-nitro-N-nitrosoguanidine. Journal of Cancer Research and Clinical Oncology. 109(2). 93–102. 5 indexed citations
15.
Sugimachi, Keizō, Ryuichiro Tamada, Takeshi Okamura, et al.. (1984). Bidirectional effects of splenectomy on the growth of syngeneic tumor in mice. Surgery Today. 14(2). 167–173. 3 indexed citations
16.
Masuda, Hidetaka, et al.. (1983). Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection. Surgery Today. 13(2). 112–116. 8 indexed citations
17.
Kodama, Yoshifumi, et al.. (1982). Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach. Surgery Today. 12(4). 244–248. 14 indexed citations
18.
Tamada, Ryuichiro, et al.. (1980). Lymphangioma of the esophagus presenting symptoms of achalasia —A case report. Surgery Today. 10(1). 59–62. 15 indexed citations
19.
Saito, Takao, et al.. (1980). Experimental gastric carcinoma induced by N-methyl-N?-nitro-N-nitrosoguanidine. Journal of Cancer Research and Clinical Oncology. 97(1). 51–62. 4 indexed citations
20.
Saito, Takao, et al.. (1980). Regression of polyploid carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine in the stomach of a dog.. PubMed. 71(2). 226–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026